Importance Short-term and long-term persistent postacute sequelae of COVID-19 (PASC)
have not been systematically evaluated. The incidence and evolution of PASC are …

Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …

Background Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are
needed to understand their recovery trajectory and additional care needs. Methods A …

Introduction: Coronavirus disease 2019 (COVID-19) is a systemic disease characterized by
a disproportionate inflammatory response in the acute phase. This study sought to identify …

Background During COVID-19, the main manifestations of the disease are not only
pneumonia but also coagulation disorders. The purpose of this study was to evaluate …

Background Monocytes and macrophages play a pivotal role in inflammation during acute
SARS-CoV-2 infection. However, their contribution to the development of post-acute …

A failure to fully recover following coronavirus disease 2019 (COVID-19) may have a
profound impact on high-functioning populations ranging from frontline emergency services …

Objectives Fatigue is a pervasive clinical symptom in coronaviruses and may continue
beyond the acute phase, lasting for several months or years. This systematic review and …

Introduction Persisting respiratory symptoms in COVID-19 survivors may be related to
development of pulmonary fibrosis. We assessed the proportion of chest CT scans and …